Showing results (61-70 of 90) with videos related to
Sort By:
Pageof 9
Cancer|August 1, 1980
Methyl CCNU and adriamycin for patients with metastatic sarcomas: a Southwest Oncology Group studyS E Rivkin, J A Gottlieb, T Thigpen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1984
Follicular large cell lymphoma: analysis and prognostic factors in 62 patientsH M Kantarjian, P McLaughlin, L M Fuller, et al.Controlled Clinical Trials|June 5, 1999
Relationship between event rates and treatment effects in clinical site differences within multicenter trials: an example from primary Pneumocystis carinii prophylaxisJ P Ioannidis, D O Dixon, M McIntosh, et al.Cancer|October 1, 1982
Phase II studies of methyl glyoxal bis-guanylhydrazone (NSC 32946) in carcinoma of the colon and lungJ Y Killen, E P Mitchell, D F Hoth, et al.Cancer Chemotherapy and Pharmacology|January 1, 1987
Flavone acetic acid (LM 975, NSC 347512). A novel antitumor agentP J O'Dwyer, D Shoemaker, D S Zaharko, et al.Hematologic Pathology|January 1, 1987
Karyotype is prognostically more important than the FAB system's distinction between myelodysplastic syndrome and acute myelogenous leukemiaE H Estey, M J Keating, D O Dixon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1983
Alternating combination chemotherapy and levamisole improves survival in multiple myeloma: a Southwest Oncology Group StudyS E Salmon, A Haut, J D Bonnet, et al.Lancet (London, England)|September 21, 1985
Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivoS Broder, R Yarchoan, J M Collins, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 1, 1995
Radiation-induced lung damage after thoracic irradiation for Hodgkin's disease: the role of fractionationB Dubray, M Henry-Amar, J H Meerwaldt, et al.Blood|August 15, 1990
High-dose melphalan and granulocyte-macrophage colony-stimulating factor for refractory multiple myelomaB Barlogie, S Jagannath, D O Dixon, et al.Pageof 9